4-55396285-G-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_018475.5(TMEM165):c.96G>T(p.Arg32Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,528,542 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00083 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000076 ( 1 hom. )
Consequence
TMEM165
NM_018475.5 synonymous
NM_018475.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.113
Genes affected
TMEM165 (HGNC:30760): (transmembrane protein 165) This gene encodes a predicted transmembrane protein with a perinuclear Golgi-like distribution in fibroblasts. Mutations in this gene are associated with the autosomal recessive disorder congenital disorder of glycosylation, type IIk. Knockdown of this gene's expression causes decreased sialylation in HEK cells and suggests this gene plays a role in terminal Golgi glycosylation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 4-55396285-G-T is Benign according to our data. Variant chr4-55396285-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 1612289.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.113 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM165 | NM_018475.5 | c.96G>T | p.Arg32Arg | synonymous_variant | 1/6 | ENST00000381334.10 | NP_060945.2 | |
TMEM165 | XM_011534394.4 | c.96G>T | p.Arg32Arg | synonymous_variant | 1/6 | XP_011532696.1 | ||
TMEM165 | XM_017008412.2 | c.-350G>T | 5_prime_UTR_variant | 1/8 | XP_016863901.1 | |||
TMEM165 | NR_073070.2 | n.329G>T | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM165 | ENST00000381334.10 | c.96G>T | p.Arg32Arg | synonymous_variant | 1/6 | 1 | NM_018475.5 | ENSP00000370736.5 | ||
TMEM165 | ENST00000506198.5 | c.96G>T | p.Arg32Arg | synonymous_variant | 1/3 | 2 | ENSP00000425449.1 | |||
TMEM165 | ENST00000508404.5 | n.96G>T | non_coding_transcript_exon_variant | 1/7 | 2 | ENSP00000422639.1 | ||||
TMEM165 | ENST00000514070.1 | n.35G>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000829 AC: 126AN: 152062Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
126
AN:
152062
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000109 AC: 14AN: 128392Hom.: 0 AF XY: 0.000111 AC XY: 8AN XY: 72314
GnomAD3 exomes
AF:
AC:
14
AN:
128392
Hom.:
AF XY:
AC XY:
8
AN XY:
72314
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000763 AC: 105AN: 1376372Hom.: 1 Cov.: 34 AF XY: 0.0000558 AC XY: 38AN XY: 681008
GnomAD4 exome
AF:
AC:
105
AN:
1376372
Hom.:
Cov.:
34
AF XY:
AC XY:
38
AN XY:
681008
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000828 AC: 126AN: 152170Hom.: 1 Cov.: 33 AF XY: 0.000780 AC XY: 58AN XY: 74404
GnomAD4 genome
AF:
AC:
126
AN:
152170
Hom.:
Cov.:
33
AF XY:
AC XY:
58
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
TMEM165-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 08, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
TMEM165-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2022 | TMEM165: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at